Related references
Note: Only part of the references are listed.Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
Jacalyn Rosenblatt et al.
BLOOD (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
A. K. Gandhi et al.
CURRENT CANCER DRUG TARGETS (2010)
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients
Yanran Cao et al.
EXPERIMENTAL HEMATOLOGY (2010)
CCR2 Plays a Critical Role in Dendritic Cell Maturation: Possible Role of CCL2 and NF-κB
Fabio Jimenez et al.
JOURNAL OF IMMUNOLOGY (2010)
No significant effect of orally administered chemokine receptor 1 antagonist on intercellular adhesion molecule-3 expression in relapsing-remitting multiple sclerosis patients
R. Reuss et al.
MULTIPLE SCLEROSIS (2010)
Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model
Takanori Kitamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653
Peter Norman
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1α and MIP-1β production
Masahiro Abe et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
Pro-Inflammatory Cytokines TNF-Related Weak Inducer of Apoptosis (TWEAK) and TNFα Induce the Mitogen-Activated Protein Kinase (MAPK)-Dependent Expression of Sclerostin in Human Osteoblasts
Cristina Vincent et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
CCR1 knockdown suppresses human non-small cell lung cancer cell invasion
Chang-Li Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
CCL5/CCR5 Axis Promotes the Motility of Human Oral Cancer Cells
Jing-Yuan Chuang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Novel Pyrrolidine Ureas as C-C Chemokine Receptor 1 (CCR1) Antagonists
J. Robert Merritt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma
M. Roussou et al.
LEUKEMIA (2009)
Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial
Clarissa E. Vergunst et al.
ARTHRITIS AND RHEUMATISM (2008)
Dynamic Modulation of CCR7 Expression and Function on Naive T Lymphocytes In Vivo
Mirjam R. Britschgi et al.
JOURNAL OF IMMUNOLOGY (2008)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts
Sonia Vallet et al.
BLOOD (2007)
Pathologic fractures correlate with reduced survival in patients with malignant bone disease
Fred Saad et al.
CANCER (2007)
Macrophage inflammatory protein-1α (MIP-1α) enhances a receptor activator of nuclear factor κB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways
Masanobu Tsubaki et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity
Livio Trentin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Teru Hideshima et al.
NATURE REVIEWS CANCER (2007)
Biochemical markers of bone turnover in diagnosis of myeloma bone disease
Omer Dizdar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
SMAD4-deficient intestinal tumors recruit CCR1(+) myeloid cells that promote invasion
Takanori Kitamura et al.
NATURE GENETICS (2007)
Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715
Alan T. Clucas et al.
CLINICAL PHARMACOKINETICS (2007)
MIP-1α (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma
Esther Masih-Khan et al.
BLOOD (2006)
Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model
Eline Menu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages
Niels R. Veillard et al.
ATHEROSCLEROSIS (2006)
Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines
Teresa Mateo et al.
JOURNAL OF IMMUNOLOGY (2006)
Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors
Marek Honczarenko et al.
STEM CELLS (2006)
Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat:: a key role for CCL9 (MIP-1γ) in osteoclastogenesis in vivo and in vitro
MH Yang et al.
BLOOD (2006)
The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice
RP Gladue et al.
JOURNAL OF IMMUNOLOGY (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A clinically relevant SCID-hu in vivo model of human multiple myeloma
P Tassone et al.
BLOOD (2005)
Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis
J Hwang et al.
CYTOKINE (2005)
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility
E Gonzalez et al.
SCIENCE (2005)
MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells
Y Oba et al.
EXPERIMENTAL HEMATOLOGY (2005)
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
K Podar et al.
BLOOD (2005)
Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1α and MIP-1β correlates with lytic bone lesions in patients with multiple myeloma
T Hashimoto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Pathogenesis of myeloma bone disease
GD Roodman
BLOOD CELLS MOLECULES AND DISEASES (2004)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
Differential role of CCR2 in islet and heart allograft rejection: Tissue specificity of chemokine/chemokine receptor function in vivo
R Abdi et al.
JOURNAL OF IMMUNOLOGY (2004)
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)
M Politou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts
XF Yu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
M Abe et al.
BLOOD (2004)
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases
RP Gladue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Serum levels of macrophage inflammatory protein-1 alpha (MIP-1α) correlate with the extent of bone disease and survival in patients with multiple myeloma
E Terpos et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Differential chemokine responses and homing patterns of murine TCRαβ NKT cell subsets
B Johnston et al.
JOURNAL OF IMMUNOLOGY (2003)
Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis
JJ Haringman et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Dual effects of macrophage inflammatory protein-1α on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease
BO Oyajobi et al.
BLOOD (2003)
Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease
F Magrangeas et al.
BLOOD (2003)
Leukotactin-1-induced ERK activation is mediated via Gi/Go protein/PLC/PKCδ/Ras cascades in HOS cells
IS Kim et al.
LIFE SCIENCES (2003)
Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells
S Lentzsch et al.
BLOOD (2003)
Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM
S Uneda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Expression and function of chemokine receptors in human multiple myeloma
C Moller et al.
LEUKEMIA (2003)
Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis
S Shahrara et al.
ARTHRITIS AND RHEUMATISM (2003)
CCR1 chemokine receptor antagonist
T Saeki et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Macrophage inflammatory protein-1
P Menten et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells:: antagonism of hCCR1 activation by MIP-1β
CC Chou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment
N Giuliani et al.
BLOOD (2001)
Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease
SJ Choi et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays
J De Vos et al.
BLOOD (2001)
Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand
JH Han et al.
BLOOD (2001)
Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1
M Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Regulation of the human chemokine receptor CCR1 - Cross-regulation by CXCR1 and CXCR2
RM Richardson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Share Paper
